ClinicalTrials.Veeva

Menu

Effects of Whole Body Vibration on Postmenopausal Risk-factors in Elderly Women

U

University of Erlangen-Nürnberg Medical School

Status and phase

Terminated
Phase 3

Conditions

Postmenopausal

Treatments

Behavioral: stretching and wellness (control group)
Device: side alternating vibration device (Board 3000 whole body vibration platform)
Device: vertical vibration device (Vibrafit whole body vibration platform)

Study type

Interventional

Funder types

Other

Identifiers

NCT00667667
OFZ-Elvis-II

Details and patient eligibility

About

There is general agreement that physical exercise can positively influence osteoporotic fracture risk along two pathways: first by reducing the risk of falls via an improvement of fall related neuromuscular abilities; second by increasing bone strength.

Whole body vibration (WBV) training has recently been proposed as a new approach for prevention and treatment of osteoporosis. Animal studies have shown evidence that WBV may be an effective method to improve bone mass, architecture and strength. However, the results of human WBV training studies are rather heterogeneous.

In the Erlangen Longitudinal Vibration Study II (ELVIS II), a randomized, controlled 12 month lasting study the investigators determine the effect of a thrice weekly WBV training on two different devices on the osteoporotic risk factors: bone mineral density, falls and neuromuscular performance. Particular the investigators compare a bipedal vertical oscillating Plate with a plate which rotates around a central axis leading to a side-alternating loaning.

Enrollment

108 patients

Sex

Female

Ages

60 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • females 60 - 75 years old
  • caucasian race

Exclusion criteria

  • CHD-diseases
  • thrombosis, embolism
  • fractures at lumbar spine or hip
  • secondary osteoporosis
  • hyperparathyroidism
  • medication, diseases with impact on muscle or bone
  • hip or knee implant

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

108 participants in 3 patient groups

1
Active Comparator group
Description:
vertical vibration device (using Vibrafit whole body vibration platforms)
Treatment:
Device: vertical vibration device (Vibrafit whole body vibration platform)
2
Active Comparator group
Description:
side-alternating vibration device (using Board 3000 whole body vibration platforms)
Treatment:
Device: side alternating vibration device (Board 3000 whole body vibration platform)
3
Sham Comparator group
Description:
wellness-control group
Treatment:
Behavioral: stretching and wellness (control group)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems